Activity of DNA vaccines encoding self or heterologous Her-2/neu in Her-2 or neu transgenic mice
- 1 April 2006
- journal article
- Published by Elsevier in Cellular Immunology
- Vol. 240 (2) , 96-106
- https://doi.org/10.1016/j.cellimm.2006.07.002
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Concurrent Induction of Antitumor Immunity and Autoimmune Thyroiditis in CD4+CD25+ Regulatory T Cell–Depleted MiceCancer Research, 2005
- Expression of a Natural Tumor Antigen by Thymic Epithelial Cells Impairs the Tumor-Protective CD4+ T-Cell RepertoireCancer Research, 2005
- A Single Vaccination with Polyomavirus VP1/VP2Her2 Virus-Like Particles Prevents Outgrowth of HER-2/neu–Expressing TumorsCancer Research, 2005
- Vaccination with dendritic cells pulsed with apoptotic tumors in combination with anti‐OX40 and anti‐4‐1BB monoclonal antibodies induces T cell–mediated protective immunity in Her‐2/neu transgenic miceInternational Journal of Cancer, 2005
- Xenogeneic immunization in mice using HER2 DNA delivered by an adenoviral vectorInternational Journal of Cancer, 2004
- p185neu protein is required for tumor and anchorage-independent growth, not for cell proliferation of transgenic mammary carcinomaInternational Journal of Cancer, 2000
- Animal Models of Myasthenia GravisClinical Immunology, 2000
- Collagen-induced arthritis, an animal model of autoimmunityLife Sciences, 1997
- The immunopathogenesis and regulation of T-cell-mediated demyelinating diseasesImmunology Today, 1994
- Early and multifocal tumors in breast, salivary, Harderian and epididymal tissues developed in MMTY-Neu transgenic miceCancer Letters, 1992